Oramed Pharmaceuticals | SCHEDULE 13G:其他
Oramed Pharmaceuticals | 4:持股變動聲明-高管 Hexter Joshua
Oramed Pharmaceuticals | 4:持股變動聲明-高管 KIDRON NADAV
Oramed Pharmaceuticals | 4:持股變動聲明-高管 Gabay Avraham
Oramed Pharmaceuticals | 4:持股變動聲明-高管 Kidron Miriam
Oramed Pharmaceuticals | 8-K:重大事件
Oramed Pharmaceuticals | 8-K:重大事件
Oramed Pharmaceuticals | 4:持股變動聲明-高管 Hexter Joshua
Oramed Pharmaceuticals | 4:持股變動聲明-高管 Kidron Miriam
Oramed Pharmaceuticals | 4:持股變動聲明-高管 KIDRON NADAV
Oramed Pharmaceuticals | 4:持股變動聲明-高管 Gabay Avraham
Oramed Pharmaceuticals | 10-Q:2024財年三季報
Oramed Pharmaceuticals | 8-K:重大事件
Oramed Pharmaceuticals | 8-K:重大事件
Oramed Pharmaceuticals | 8-K:重大事件
Oramed Pharmaceuticals | 8-K:重大事件
Oramed Pharmaceuticals | SC 13G:超過5%持股股東披露文件-BML Investment Partners, L.P.(5.0%)
Oramed Pharmaceuticals | 10-Q:2024財年二季報
Oramed Pharmaceuticals | 8-K:重大事件
Oramed Pharmaceuticals | 8-K:重大事件